Here, we report the first case of a female patient with a diagnosis of stage IV lung adenocarcinoma harboring the <i>EML4::NTRK3</i> gene fusion, and successfully treated with entrectinib. This evidence concerns the gene NTRK3 and lung adenocarcinoma.